Skip to content

Pentazocine-Suppository Paracetamol Versus Pentazocine-Suppository Diclofenac for Post-Caesarean Section Pain Relief: A Randomized Controlled Trial

Pentazocine-Suppository Paracetamol Versus Pentazocine-Suppository Diclofenac for Post-Caesarean Section Pain Relief: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202407781417769
Enrollment
288
Registered
2024-07-29
Start date
2024-09-16
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Caesarean section pain relief.

Interventions

Group A
Group B

Sponsors

MODUPEOLA IBRAHIM
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All consenting parturient aged 18 years and above scheduled for elective or emergency Caesarean section under regional anesthesia

Exclusion criteria

Exclusion criteria: 1. History of peptic ulcer disease 2. Patients who had Caesarean delivery under general anesthesia 3. History of hypersensitivity reaction to pentazocine, paracetamol or diclofenac 4. Severe Pre-eclampsia/Eclampsia 5. Renal and hepatic dysfunction 6. Patients who develop postoperative complications such as PPH 7. Any patient that will require special post-delivery pain control, such as sickle cell disease patients 8. Unconscious patient (GCS <=7)

Design outcomes

Primary

MeasureTime frame
The visual analogue pain score will be used to quantify post-operative pain management as the primary end measure

Secondary

MeasureTime frame
patient satisfaction, the length of time an analgesic medication relieves pain, the need for rescue analgesia and unfavorable outcomes for mothers.

Countries

Nigeria

Contacts

Public ContactJOY CHIONUMA

SUPERVISING CONSULTANT

agbara.joy2012@gmail.com+2348028350052

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026